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Coprecipitation leads to self-assembly of bioactive DNA on the
surface of salt, sugar or amino-acid crystals and provides a
rapid inexpensive immobilization method suitable for preparing
dry-powder formulations of nucleic acids, useful for storage,
imaging and drug delivery.
Processing of biomolecules into dry powders is carried out on a
substantial scale in both the academic and commercial environ-
ment, and serves as a powerful stabilisation and storage method.1
Of particular current interest is the production of well defined
particles as they can form the starting point for making new
functional biomaterials with applications in a number of areas
including drug delivery, diagnostics, biocatalysis and screening.
Hitherto, mature but complex technologies such as freeze-drying
and spray-drying have been used for drying biomolecules, but
these are time, energy and capital intensive and often provide
particles with a limited range of physiochemical characteristics.1,2
By comparison it is noteworthy that Nature assembles a wide
variety of functional materials rapidly and spontaneously under
ambient conditions. Therefore, alternative biomimetic approaches
are being increasingly explored.3
Here we describe a coprecipitation process that leads to
spontaneous immobilisation of dehydrated DNA onto the surface
of water-soluble microcrystals. A critical component is the co-
precipitant which must crystallise rapidly under high super-
saturation conditions. It should also be aqueous soluble with
negligible solubility in the particular water-miscible organic solvent
used. Suitable crystalline carriers are amino-acids, salts and certain
sugars and these can be used in combination with water-miscible
solvents such as alcohols and acetone. The preparation of DNA-
coated microcrystals (DCMC) is straightforward and applicable in
any laboratory. An aqueous mixture is formed containing the
DNA and a near saturated solution of the co-precipitant. This is
then added drop-wise to a large excess of the solvent while mixing
vigorously. Immediately a fine white co-precipitate can be
observed that is made up entirely of DCMC. These microcrystals
may be stored as a suspension or alternatively filtered/centrifuged,
rinsed with solvent and air-dried to form a fine free-flowing
powder. Significantly, coating of microcrystals during coprecipita-
tion has proven to be an example of a generic bottom-up self-
organisation process that we have termed crystal lattice mediated
self-assembly (CLAMS). As well as nucleic acids it can be applied
to peptides, proteins4 and nanoparticles.5
In this work the coprecipitant used was DL-valine. This is non-
hygroscopic, has a convenient saturated aqueous concentration of
around 80 mg/ml and tends to crystallise in the form of flat plates.
For the initial experiments crude oligonucleotides prepared from
herring sperm were used. DCMC were produced by adding an
aqueous DNA/valine mixture to an excess of 2-propanol{. The
morphology of particles produced was assessed using Scanning
Electron Microscopy (SEM). A control sample of valine
precipitated in 2-propanol in the absence of DNA was found
to contain thin plate-like crystals with dimensions of between
5–15 mm (Fig. 1a). No major surface features are visible (Fig. 1b).
The sample obtained upon co-precipitation of the oligonucleo-
tides (, 50 bp) with the valine (10 wt% DNA loading) also
contained crystals with similar morphology to the control (Fig. 1c).
Significantly, when these were imaged at higher magnification
(Fig. 1d) the surface structure was found to be different and was
characterised by the presence of round clusters (, 100 nm). These
features are attributed to clusters of DNA on the surface.
Employing larger DNA (y2000 bp) produced the same crystal
morphology and surface features. Importantly a second control
sample obtained by precipitation of pure DNA into 2-propanol
contained no crystals and only large oligonucleotide aggregates
were observed{. To provide a better statistical analysis of particle
{ Electronic supplementary information (ESI) available: SEM of DNA,
redissolution experiment, PCR data and experimental details. See http://
www.rsc.org/suppdata/cc/b5/b501045d/
Fig. 1 SEM images of valine crystals, produced in the absence of DNA
(a) and (b) and DNA-coated microcrystals produced with valine and crude
oligonucleotides (, 50 bp) (c) and (d). Higher magnification images of a
single valine crystal (b) and a DNA-coated microcrystal (d). Precipitation
was into 2-propanol with a DNA loading of 10 wt%.
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size, light-scattering measurements were carried out on a
suspension of microcrystals in 2-propanol. The mean particle size
of DCMC, produced with valine and DNA (y2000 bp, 10 wt%
DNA loading), was found to be 13 mm. This is in good agreement
with DCMC sizes obtained from SEM. Furthermore, light-
scattering particle sizing indicated a narrow size distribution
showing the SEM images obtained are representative (Span5 1.6).
The presence of the clusters in the SEM images suggests that
DNA is present at the crystal surface. To investigate this further
Confocal Laser Scanning Fluorescence Microscopy was carried
out using a synthetic fluorescently-labelled oligonucleotide, DQA-
HEX§ coated onto the valine core (0.3 wt% loading). The
fluorescence emitted by DQA-HEX oligonucleotide was found to
correspond faithfully to the position of the crystals, outlining
geometric shapes with dimensions of approximately 5–15 mm
(Fig. 2a). This is in good agreement with particle sizes determined
by SEM. Additionally, the highest fluorescence intensity is found
on the crystal edges as expected if the oligonucleotides are located
on the carrier crystal surface. Further strong evidence that the
majority of oligonucleotides are immobilised on the surface was
obtained on suspension of the crystals in saturated aqueous valine
solution as detailed in the ESI{. The DNA was found to
immediately dissolve while the crystals remained intact.
In order for the DNA-coated microcrystals to be useful it is
critical that bioactivity is retained. Therefore, we assessed if the
oligonucleotides were compromised by the process. The oligo-
nucleotide DQA-HEX§ was used to coat valine crystals and
following redissolution tested as one of the primers in a PCR
reaction. Processed DQA-HEX and unprocessed DQA-HEX
(control) showed the same efficiency for DNA amplification (See
ESI{). Sequencing data of the PCR products also confirmed that
the right gene product was amplified in the PCR. Furthermore, it
was found that the end sequence of the PCR product, which is
dictated by the DQA-HEX primer, was identical and that no bases
were altered or truncated. This demonstrates that the process for
preparing DCMC is benign.
Having shown that short oligonucleotides retained bioactivity
we were interested in looking at longer DNA sequences, in
particular possible candidates for drug delivery, such as plasmids.
A green fluorescence protein (GFP) construct was used for these
studies because transfection efficiency can be easily followed by
GFP expression. DNA-coated microcrystals were prepared using
GFP-ARF plasmid and valine and following reconstitution used
to transfect HeLa cells. As shown in Fig. 2b approximately 20% of
the cells were successfully transfected. This is very similar to the
result obtained with untreated plasmid and demonstrates that a
complete plasmid can be passed through the DCMC process with
good retention of bioactivity.
In conclusion we have shown for the first time that a
straightforward coprecipitation process can be used to simulta-
neously dehydrate and immobilise DNA onto the surface of water-
soluble microcrystals. Importantly there is no discernable loss of
bioactivity, as judged both by PCR and transfection. The coated
valine crystals are free-flowing, non-hygroscopic and easy to
handle and provide a convenient carrier to store, handle and image
DNA, RNA and their conjugates. Improvements to the process
are expected to yield crystals with a size and morphology suitable
for pulmonary drug-delivery applications including non-viral gene
therapy.
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may be dissolved into the valine solution.) This mixture was added drop-
wise to 15 ml of 2-propanol (saturated with DL-valine) while stirring
vigorously with a magnetic stirrer bar. The resulting DCMC were
separated by filtration, thoroughly washed with 2-propanol (saturated
with DL-valine) and either air-dried or resuspended in 2-propanol
(saturated with DL-valine). This produces a theoretical loading of DNA
of 18.2 wt%. See also ESI.
§ DQA-HEX 5 59-HEX (T*C)6 GTG CTG CAG GTG TAA ACT TGT
ACC AG, HEX5 2,5,29,49,59,79-hexachloro-6-carboxyfluorescein, T*5 5-
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Fig. 2 (a) Fluorescence emitted by microcrystals of valine coated with
fluorescently labelled oligonucleotide DQA-HEX. (b) Green fluorescence
of HeLa cells 24 h after transfection with GFP-ARF plasmid/valine
microcrystals (0.1 wt% DNA loading).
2676 | Chem. Commun., 2005, 2675–2676 This journal is  The Royal Society of Chemistry 2005
D
ow
nl
oa
de
d 
on
 0
1 
Ju
ly
 2
01
1
Pu
bl
ish
ed
 o
n 
20
 A
pr
il 
20
05
 o
n 
ht
tp
://
pu
bs
.rs
c.o
rg
 | d
oi:
10.
103
9/B
501
045
D
View Online
